Prenetics Global Ltd (PRE) - Total Assets

Latest as of September 2025: $196.51 Million USD

Based on the latest financial reports, Prenetics Global Ltd (PRE) holds total assets worth $196.51 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Prenetics Global Ltd (PRE) shareholders funds for net asset value and shareholders' equity analysis.

Prenetics Global Ltd - Total Assets Trend (2000–2024)

This chart illustrates how Prenetics Global Ltd's total assets have evolved over time, based on quarterly financial data.

Prenetics Global Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Prenetics Global Ltd's total assets of $196.51 Million consist of 40.3% current assets and 59.7% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 24.5%
Accounts Receivable $5.61 Million 2.6%
Inventory $6.57 Million 3.1%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $11.57 Million 5.4%
Goodwill $37.36 Million 17.5%

Asset Composition Trend (2000–2024)

This chart illustrates how Prenetics Global Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Prenetics Global Ltd (PRE) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Prenetics Global Ltd's current assets represent 40.3% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 24.5% of total assets in 2024, up from 7.1% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 14.0% in 2000.
  • Asset Diversification: The largest asset category is goodwill at 17.5% of total assets.

Prenetics Global Ltd Competitors by Total Assets

Key competitors of Prenetics Global Ltd based on total assets are shown below.

Company Country Total Assets
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Eurofins-Cerep SA
PA:ALECR
France €84.58 Million
Inoviq Ltd
AU:IIQ
Australia AU$24.52 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million
Imagion Biosystems Ltd
AU:IBX
Australia AU$932.48K
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million

Prenetics Global Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.51 1.40 0.93
Quick Ratio 1.30 1.22 0.84
Cash Ratio 0.00 0.00 0.00
Working Capital $13.00 Million $19.80 Million $-3.11 Million

Prenetics Global Ltd - Advanced Valuation Insights

This section examines the relationship between Prenetics Global Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.28
Latest Market Cap to Assets Ratio 1.22
Asset Growth Rate (YoY) -16.0%
Total Assets $213.57 Million
Market Capitalization $259.51 Million USD

Valuation Analysis

Above Book Valuation: The market values Prenetics Global Ltd's assets above their book value (1.22x), reflecting positive investor sentiment about the company's future prospects.

Significant Asset Reduction: Prenetics Global Ltd's assets decreased by 16.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Prenetics Global Ltd (2000–2024)

The table below shows the annual total assets of Prenetics Global Ltd from 2000 to 2024.

Year Total Assets Change
2024-12-31 $213.57 Million -15.97%
2023-12-31 $254.17 Million -18.57%
2022-12-31 $312.13 Million +110.18%
2021-12-31 $148.51 Million +88.26%
2020-12-31 $78.88 Million +165.72%
2019-12-31 $29.69 Million -99.86%
2015-12-31 $21.41 Billion -3.88%
2014-12-31 $22.27 Billion -3.33%
2013-12-31 $23.04 Billion +0.25%
2012-12-31 $22.98 Billion +0.55%
2011-12-31 $22.86 Billion -2.18%
2010-12-31 $23.36 Billion -1.55%
2009-12-31 $23.73 Billion +45.78%
2008-12-31 $16.28 Billion +1.51%
2007-12-31 $16.04 Billion +7.28%
2006-12-31 $14.95 Billion +8.76%
2005-12-31 $13.74 Billion +9.85%
2004-12-31 $12.51 Billion +14.75%
2003-12-31 $10.90 Billion +24.78%
2002-12-31 $8.74 Billion +21.95%
2001-12-31 $7.17 Billion +17.63%
2000-12-31 $6.09 Billion --

About Prenetics Global Ltd

NASDAQ:PRE USA Diagnostics & Research
Market Cap
$259.51 Million
Market Cap Rank
#15538 Global
#3508 in USA
Share Price
$17.02
Change (1 day)
+1.86%
52-Week Range
$5.19 - $22.15
All Time High
$120.81
About

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more